Effect of Riboflavin/Rose Bengal-Mediated PACK-CXL on Acanthamoeba Trophozoites and Cysts in Vitro

被引：33
作者：
Atalay, Hatice Tuba [1 ]
Dogruman-Al, Funda [2 ]
Sarzhanov, Fakhriddin [2 ,3 ]
Ozmen, Mehmet Cuneyt [1 ]
Tefon, Atike Burcin [1 ]
Aribas, Yavuz Kemal [1 ]
Bilgihan, Kamil [1 ]
机构：
[1] Gazi Univ, Sch Med, Dept Ophthalmol, 13th Floor, TR-06500 Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Med Microbiol, Ankara, Turkey
[3] Ahmet Yesevi Int Kazakh Turkish Univ, Sch Med, Turkestan, Kazakhstan
来源：
CURRENT EYE RESEARCH | 2018年 / 43卷 / 11期
关键词：
0.1% and 0.25% riboflavin; 0.1% and 0.2% rose bengal; antiamoebic efficacy; photochemical cross-linking (PACK-CXL); acanthamoeba; COLLAGEN CROSS-LINKING; INFECTIOUS KERATITIS; ROSE-BENGAL; PHOTODYNAMIC THERAPY; ULTRAVIOLET; EFFICACY; UPDATE; DIAGNOSIS; AGENTS; LIGHT;
D O I：
10.1080/02713683.2018.1501074
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Purpose: To evaluate the antiamoebic properties of photo-activated chromophore for keratitis (PACK)-corneal cross-linking (CXL) (PACK-CXL), in combination with riboflavin (0.1 and 0.25%) or rose bengal (0.1 and 0.2%), for treatment of Acanthamoeba trophozoites and cysts.Materials and Methods: Cultures of Acanthamoeba castellanii were grown in a fluid medium at a concentration of 2.7x10(5) cell/ml. PACK-CXL was used on A. castellani cells in combination with either riboflavin (0.1 and 0.25%) or rose bengal (0.1 and 0.2%). Riboflavin-containing wells were irradiated with ultraviolet-A (UVA) light (365-nm wavelength). Rose bengal-containing wells were irradiated with green light (523-nm wavelength). A power density of 9mW/cm(2) for 10min and total irradiation dose of 5.4J/cm(2) was used for both riboflavin and rose bengal. After UVA and green light irradiation, cell viabilities were evaluated, and percentage of dead cells calculated.Results: No significant amoebicidal activity was observed following PACK-CXL/riboflavin at either concentration. PACK-CXL/rose bengal, however, was observed to be highly effective in eradicating Acanthamoeba cells at either concentration, with no significant difference observed between the two concentrations. The percentage of dead cells was 63% following treatment at either rose bengal concentration.Conclusion: PACK-CXL with rose bengal demonstrated pronounced antiamoebic activity against A.castellanii. Further in vitro and in vivo studies are needed to confirm this finding.
引用
收藏
页码：1322 / 1325
页数：4
相关论文
共 29 条
[11]   Rose Bengal- and Riboflavin-Mediated Photodynamic Therapy to Inhibit Methicillin-Resistant Staphylococcus aureus Keratitis Isolates [J].
Halili, Francisco ;
Arboleda, Alejandro ;
Durkee, Heather ;
Taneja, Mukesh ;
Miller, Darlene ;
Alawa, Karam A. ;
Aguilar, Mariela C. ;
Amescua, Guillermo ;
Flynn, Harry W., Jr. ;
Parel, Jean-Marie .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 166 :194-202
[12]   Expert practice patterns and opinions on corneal cross-linking for infectious keratitis [J].
Hsia, Yen C. ;
Moe, Caitlin A. ;
Lietman, Thomas M. ;
Keenan, Jeremy D. ;
Rose-Nussbaumer, Jennifer .
BMJ OPEN OPHTHALMOLOGY, 2018, 3 (01)
[13]   Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts [J].
Iseli, Hans Peter ;
Thiel, Michael A. ;
Hafezi, Farhad ;
Kamptneier, Juergen ;
Seiler, Theo .
CORNEA, 2008, 27 (05) :590-594
[14]   Assessing Efficacy of Combined Riboflavin and UV-A Light (365 nm) Treatment of Acanthamoeba Trophozoites [J].
Kashiwabuchi, Renata T. ;
Carvalho, Fabio R. S. ;
Khan, Yasin A. ;
de Freitas, Denise ;
Foronda, Annette S. ;
Hirai, Flavio E. ;
Campos, Mauro S. ;
McDonnell, Peter J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (13) :9333-9338
[15]   Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis Report of 3 Cases [J].
Khan, Yasin A. ;
Kashiwabuchi, Renata T. ;
Martins, Suy Anne ;
Castro-Combs, Juan M. ;
Kalyani, Sachin ;
Stanley, Philip ;
Flikier, David ;
Behrens, Ashley .
OPHTHALMOLOGY, 2011, 118 (02) :324-331
[16]   Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts [J].
Lamy, Ricardo ;
Chan, Elliot ;
Good, Samuel D. ;
Cevallos, Vicky ;
Porco, Travis C. ;
Stewart, Jay M. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 (03) :181-187
[17]   Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis [J].
Lim, Natasha ;
Goh, David ;
Bunce, Catey ;
Xing, Wen ;
Fraenkel, Graham ;
Poole, Tom R. G. ;
Ficker, Linda .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (01) :130-135
[18]   An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment [J].
Lorenzo-Morales, Jacob ;
Khan, Naveed A. ;
Walochnik, Julia .
PARASITE, 2015, 22
[19]   Acanthamoeba spp. as agents of disease in humans [J].
Marciano-Cabral, F ;
Cabral, G .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (02) :273-+
[20]   Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis [J].
Martins, Suy Anne R. ;
Combs, Juan Castro ;
Noguera, Guillermo ;
Camacho, Walter ;
Wittmann, Priscila ;
Walther, Rhonda ;
Cano, Marisol ;
Dick, James ;
Behrens, Ashley .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (08) :3402-3408
123